In the nearly 40 years since scientists first nailed down the Ebola virus, drug researchers have yet to commercialize an effective therapy for the deadly disease, a problem made worse by a lack of commercial promise and the relative rarity of outbreaks.

…read more

Source: Ebola still a tough target due to Big Pharma disinterest and few outbreaks